Binding of MCP-1 to its receptor CCR2 on tumour cells enhances tumour cell proliferation, migration, invasion, and angiogenesis (19,20), partly through activation of the ERK signalling cascade and secretion of proteases (21). Here, CCR2 is linked to neoplasm.